Home > > > > Report Detail

Artificial Intelligence in Drug Discovery Market by Offering, Process (Target selection, Validation, Lead generation, optimization), Drug design (Small molecule, Vaccine, Antibody, PK/PD), Dry Lab, Wet Lab (Single Cell analysis) - Global Forecast to 2028

Publisher Name :
Date: 13-Nov-2023
No. of pages: 200
Inquire Before Buying

“Global Artificial Intelligence (AI) in Drug Discovery Market to register a CAGR of 40.2% from 2023 to 2028”

The artificial intelligence (AI) in drug discovery market is projected to reach USD 4.9 billion by 2028 from USD 0.9 billion in 2023, at a CAGR of 40.2% during the forecast period. AI expedites the identification and validation of potential drug targets by analyzing intricate biological data. This accelerates the selection of biologically relevant targets for therapeutic interventions. AI techniques such as machine learning enable rapid analysis and decision-making, reducing the time and resources required for drug discovery processes. This efficiency gains a competitive edge in the fast-paced pharmaceutical landscape. Therefore, aforementioned factors will drive the growth of this market.  On the other hand, the inadequate availability of skilled labor is key factor restraining the market growth to a certain extent over the forecast period.  

“Services segment is estimated to hold the major share in 2022 and also expected to grow at the highest over the forecast period.”

Based on offering, the AI in drug discovery market is bifurcated into software and services. The2022 and segment expected to account for the largest market share of the global AI in drug discovery services market in 2022 and expected to grow fastest CAGR during the forecast period. Access to AI technology and expertise through services reduces the barriers for pharmaceutical companies to adopt AI in drug discovery. This is particularly beneficial for smaller companies without extensive in-house AI capabilities, enabling them to harness the power of AI without significant upfront investments.

“Machine learning technology segment accounted for the largest share of the global AI in drug discovery market.”

Based on technology, the AI in drug discovery market is segmented into machine learning, natural language processing (NLP), context aware processing, and other technologies. The machine learning segment accounted for the largest share of the global market in 2022 and expected to grow at the highest CAGR during the forecast period. Machine learning enables the creation of predictive models that anticipate the behavior of potential drug candidates within the human body. This aids in identifying compounds with the highest likelihood of success, reducing the costs and time associated with unsuccessful candidates. Machine learning contributes to the development of personalized treatment strategies by analyzing patient data to predict individual responses to drugs. This facilitates tailoring treatments based on genetic, molecular, and clinical information, leading to more effective outcomes, which helps accelerate the drug discovery process are some of the factors supporting the market growth of this segment.

“Small Molecule Design and Optimization segment expected to hold the largest share of use case segment of the market in 2022.”

Based on use cases, the AI in drug discovery market is divided into small molecule design and optimization, understanding disease, safety and toxicity, vaccine design and optimization, antibody and other biologics design and optimization. In 2022, the small molecule design and optimization segment accounted for the largest share of the AI in drug discovery market. AI is employed in small molecule design and optimization for two main purposes. Firstly, it aids in identifying hit-like or lead-like compounds by screening existing chemical libraries or through generative de novo design. Secondly, AI optimizes the identified hits, ensuring favorable properties like binding affinity, toxicity, and synthesis, ultimately leading to the development of more effective and safer drug candidates. These factors contribute to the development and refinement of AI algorithms tailored for drug discovery use cases.

“North America to dominate the AI in drug discovery market in 2022”

The global AI in the drug discovery market is segmented into four major regions, namely, North America, Europe, APAC, and the Rest of the World. In 2022, North America accounted for the largest and the fastest-growing regional market for AI in drug discovery. North America hosts numerous pharmaceutical giants and biotechnology innovators that are actively exploring AI's capabilities in drug discovery. These industry leaders are investing significantly in AI-driven research and development, driving market growth. North America's well-established regulatory framework for pharmaceuticals and healthcare facilitates the integration of AI technologies while ensuring compliance with industry standards and guidelines. The above-mentioned factors will drive the market of AI in drug discovery in North America.

Breakdown of supply-side, demand side, primary interviews, by company type, designation, and region:


  • By Company Type:

  • By Supply Side: Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)

  • By Demand Side: Purchase Managers (45%), Head of Artificial Intelligence, Machine Learning, Drug Discovery, and Computational Molecular Design (30%) and Research Scientists (25%).

  • By Designation: C-level (31%), Director-level (25%), and Others (44%)

  • By Region: North America (45%), Europe (20%), Asia Pacific (28%), South America (4%) and Middle East &   Africa (3%).


The prominent players in this market are NVIDIA Corporation (US), Exscientia (UK), BenevolentAI (UK), Recursion (US), Insilico Medicine (US), Schrödinger, Inc. (US), Microsoft Corporation (US), Google (US), Atomwise Inc. (US), Illumina, Inc. (US), NuMedii, Inc. (US), XtalPi Inc. (US), Iktos (France), Tempus Labs (US), Deep Genomics, Inc. (Canada), Verge Genomics (US), BenchSci (Canada), Insitro (US), Valo Health (US), BPGbio, Inc. (US), IQVIA Inc (US), Labcorp (US), Tencent Holdings Limited (China), Predictive Oncology, Inc. (US), Celsius Therapeutics (US), CytoReason (Israel), Owkin, Inc. (US), Cloud Pharmaceuticals (US), Evaxion Biotech (Denmark), Standigm (South Korea), BIOAGE (US), Envisagenics (US), and Aria Pharmaceuticals, Inc. (US). Players adopted organic as well as inorganic growth strategies such as product launches and enhancements, and investments, partnerships, collaborations, joint ventures, funding, acquisition, expansions, agreements, sales contracts, and alliances to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage


  • The report studies the AI in drug discovery market based on offering, technology, therapeutic area, use case, process, end user, and region.  

  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.

  • The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total AI in drug discovery market.

  • The report forecasts the revenue of market segments with respect to five major regions.


Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:


  • Analysis of key drivers (growing number of cross-industry collaborations and partnerships, growing need to control drug discovery & development costs and reduce time involved in drug development, patent expiry of several drugs), restraints (shortage of AI workforce and ambiguous regulatory guidelines for medical software), opportunities (growing biotechnology industry, emerging markets, focus on developing human-aware AI systems, growth in the drugs and biologics market despite the COVID-19 pandemic), and challenges (limited availability of data sets) influencing the growth of AI in drug discovery market.

  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the AI in drug discovery market.

  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of AI in drug discovery solutions across regions.

  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the AI in drug discovery market.

  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the AI in drug discovery market.

Artificial Intelligence in Drug Discovery Market by Offering, Process (Target selection, Validation, Lead generation, optimization), Drug design (Small molecule, Vaccine, Antibody, PK/PD), Dry Lab, Wet Lab (Single Cell analysis) - Global Forecast to 2028

Table Of Contents

1 Introduction 38
1.1 Study Objectives 38
1.2 Market Definition 38
1.2.1 Inclusions And Exclusions 39
1.3 Market Scope 40
1.3.1 Market Segmentation 40
Figure 1 Ai In Drug Discovery Market: Market Segmentation 40
1.3.2 Regional Scope 41
1.3.3 Years Considered 41
1.3.4 Currency Considered 42
Table 1 Exchange Rates Utilized For Conversion To Usd 42
1.4 Stakeholders 42
1.5 Summary Of Changes 43
1.5.1 Recession Impact 44

2 Research Methodology 45
2.1 Research Data 45
Figure 2 Research Design 45
2.2 Secondary Sources 46
2.2.1 Key Data From Secondary Sources 47
2.3 Primary Data 47
2.3.1 Primary Sources 48
2.3.1.1 Key Data From Primary Sources 49
2.3.1.2 Key Industry Insights 50
2.3.2 Breakdown Of Primary Interviews 50
Figure 3 Breakdown Of Primary Interviews: By Demand Side,
Supply Side, Designation, And Region 50
2.4 Market Size Estimation 51
Figure 4 Supply-Side Market Estimation: Revenue Share Analysis 52
Figure 5 Bottom-Up Approach: End-User Spending On Ai In Drug Discovery 53
Table 2 Factor Analysis 55
Figure 6 Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges (2022–2027) 56
Figure 7 Cagr Projections: Supply-Side Analysis 56
Figure 8 Top-Down Approach 57
2.5 Market Breakdown And Data Triangulation 58
Figure 9 Data Triangulation Methodology 58
2.6 Assumptions 59
2.6.1 Market Sizing Assumptions 59
2.6.2 Overall Study Assumptions 59
2.7 Limitations 60
2.8 Risk Assessment 60
Table 3 Risk Assessment: Ai In Drug Discovery Market 60
2.9 Recession Impact Analysis 61
Table 4 Global Inflation Rate Projections, 2021–2027 (% Growth) 61
Table 5 Us Health Expenditure, 2019–2022 (Usd Million) 61
Table 6 Us Health Expenditure, 2023–2027 (Usd Million) 62

3 Executive Summary 63
Figure 10 Artificial Intelligence In Drug Discovery Market, By Offering, 2023 Vs. 2028 (Usd Million) 63
Figure 11 Artificial Intelligence In Drug Discovery Market, By Technology, 2023 Vs. 2028 (Usd Million) 64
Figure 12 Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2023 Vs. 2028 (Usd Million) 64
Figure 13 Artificial Intelligence In Drug Discovery Market, By Process,
2023 Vs. 2028 (Usd Million) 65
Figure 14 Artificial Intelligence In Drug Discovery Market, By Use Case,
2023 Vs. 2028 (Usd Million) 66
Figure 15 Artificial Intelligence In Drug Discovery Market, By End User, 2023 Vs. 2028 (Usd Million) 66
Figure 16 Artificial Intelligence In Drug Discovery Market: Geographical Snapshot 67

4 Premium Insights 68
4.1 Attractive Opportunities For Players In Ai In Drug Discovery Market 68
Figure 17 Growing Number Of Cross-Industry Collaborations & Partnerships To Drive Market 68
4.2 Ai In Drug Discovery Market: Regional Landscape 69
Figure 18 North America To Dominate Ai In Drug Discovery Market During Forecast Period 69
4.3 Ai In Drug Discovery Market: Geographic Growth Opportunities 69
Figure 19 Us To Register Highest Revenue Growth From 2023 To 2028 69
4.4 North American Ai In Drug Discovery Market, By End User & Country, 2022 70
Figure 20 Pharmaceutical & Biotechnology Companies And Us Held Largest Share In North America, 2022 70
4.5 Ai In Drug Discovery Market, By Offering 70
Figure 21 Services To Hold Majority Market Share In 2028 70
4.6 Ai In Drug Discovery Market, By Technology 71
Figure 22 Machine Learning To Retain Market Leadership Till 2028 71
4.7 Ai In Drug Discovery Market, By Therapeutic Area 71
Figure 23 Oncology To Dominate Market In 2028 71
4.8 Ai In Drug Discovery Market, By Process 72
Figure 24 Hit-To Lead Identification/Lead Generation To Dominate Market In 2028 72
4.9 Ai In Drug Discovery Market, By Use Case 72
Figure 25 Small Molecule Design & Optimization To Register Highest Growth Over Forecast Period 72
4.10 Ai In Drug Discovery Market, By End User 73
Figure 26 Pharmaceutical & Biotechnology Companies To Account For Largest Market Share In 2028 73

5 Market Overview 74
5.1 Introduction 74
5.2 Market Dynamics 74
Figure 27 Ai In Drug Discovery: Market Dynamics 74
Table 7 Ai In Drug Discovery Market: Impact Analysis 75
5.2.1 Drivers 75
5.2.1.1 Growing Cross-Industry Collaborations And Partnerships 75
Table 8 Indicative List Of Collaborations And Partnerships (2021−2023) 76
5.2.1.2 Growing Need To Reduce Time And Cost Of Drug Discovery And Development 77
5.2.1.3 Patent Expiry Of Several Drugs 77
Table 9 Indicative List Of Drugs Losing Patents In 2023 78
5.2.2 Restraints 78
5.2.2.1 Shortage Of Ai Workforce And Ambiguous Regulatory Guidelines For Medical Software 78
5.2.3 Opportunities 79
5.2.3.1 Growing Biotechnology Industry 79
5.2.3.2 Emerging Markets 79
5.2.3.3 Focus On Developing Human-Aware Ai Systems 80
5.2.4 Challenges 80
5.2.4.1 Limited Availability Of Data Sets 80
5.2.4.2 Lack Of Required Tools And Usability 80

6 Industry Insights 82
6.1 Overview Of Key Industry Trends 82
6.1.1 Evolution Of Ai In Drug Discovery 82
Figure 28 Evolution Of Ai In Drug Discovery Market 83
6.1.2 Computer-Aided Drug Design And Ai 84
Figure 29 Structure-Based Drug Designing: Ai In Drug Discovery Market 84
6.2 Supply Chain Analysis 84
Figure 30 Ai In Drug Discovery Market: Supply Chain Analysis (2022) 85
6.3 Porter’s Five Forces Analysis 85
Table 10 Ai In Drug Discovery Market: Porter’s Five Forces Analysis 85
6.3.1 Intensity Of Competitive Rivalry 85
6.3.2 Bargaining Power Of Buyers 85
6.3.3 Bargaining Power Of Suppliers 86
6.3.4 Threat Of Substitutes 86
6.3.5 Threat Of New Entrants 86
6.4 Ecosystem/Market Map 86
Figure 31 Ai In Drug Discovery Market Ecosystem 86
6.5 Technology Analysis 87
Figure 32 Ai In Drug Discovery Market: Classification 87
6.5.1 Dry Lab Services 87
6.5.2 Wet Lab Services 90
6.5.2.1 Chemistry Services 90
6.5.2.2 Biological Services 91
6.5.2.2.1 Single-Cell Analysis 92
6.6 Pricing Analysis 95
6.6.1 Average Selling Price Trends, By Region 95
6.6.2 Indicative Pricing Analysis, By Process 96
Table 11 Ai In Drug Discovery Market: Indicative Pricing, By Process 96
6.7 Business Models 96
Figure 33 Ai In Life Sciences: Business Models 97
Figure 34 Benefits Of Hybrid Business Models 97
Figure 35 Specialization Of Ai Companies Over Time 98
6.8 Case Study Analysis 99
6.8.1 Case Study 1: Bristol Myers Squibb And Exscientia 99
6.8.2 Case Study 2: Apeiron Llc And Exscientia 100
6.9 Regulatory Analysis 101
6.9.1 Ai In Drug Discovery Market: Regulatory Landscape, By Region 101
6.9.2 Regulatory Bodies, Government Agencies, And Other Organizations 103
Table 12 List Of Regulatory Bodies, Government Agencies, And Other Organizations 103
6.10 Patent Analysis 104
Figure 36 Top Patent Owners And Applicants For Ai In Drug Discovery Solutions (January 2011–October 2023) 104
Figure 37 Ai In Drug Discovery Market: Patent Analysis (January 2011–October 2023) 105
Figure 38 Top Applicant Countries/Regions For Ai In Drug Discovery Patents (January 2012–July 2023) 105
Table 13 List Of Patents/Patent Applications In Ai In Drug Discovery Market, 2021–2023 106
6.11 Key Conferences & Events (Q1 2023–Q2 2024) 108
6.12 Trends/Disruptions Impacting Customers’ Businesses 109
Figure 39 Revenue Shift In Ai In Drug Discovery Market 109
6.13 Key Stakeholders & Buying Criteria 109
6.13.1 Key Stakeholders In Buying Process 109
Figure 40 Influence Of Stakeholders On Buying Process Of Ai In Drug Discovery Market 109
6.13.2 Buying Criteria For Ai In Drug Discovery Market 110
Figure 41 Key Buying Criteria For End Users 110
6.14 Ai-Derived Clinical Assets 110
Table 14 Key Ai-Derived Clinical Assets, By Company 110
6.15 Unmet Needs 120
6.15.1 Unmet Needs In Ai In Drug Discovery 120
6.15.2 Single-Cell Analysis Landscape: Key Challenges And Pain Points In Drug Discovery 121
6.15.3 Key Unmet Needs And Pain Points For Ai Applications In Single-Cell Analysis For Drug Discovery 122

7 Artificial Intelligence In Drug Discovery Market, By Offering 123
7.1 Introduction 124
Table 15 Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 124
7.2 Services 124
7.2.1 Services Segment To Witness Highest Growth 124
Table 16 Artificial Intelligence In Drug Discovery Market For Services, By Country, 2021–2028 (Usd Million) 125
7.3 Software 125
7.3.1 Benefits Of Software In Drug Discovery And Strong Demand Among End Users To Drive Growth 125
Table 17 Artificial Intelligence In Drug Discovery Market For Software, By Country, 2021–2028 (Usd Million) 126

8 Artificial Intelligence In Drug Discovery Market, By Technology 127
8.1 Introduction 128
Table 18 Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 128
8.2 Machine Learning 128
Table 19 Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 129
Table 20 Artificial Intelligence In Drug Discovery Market For Machine Learning, By Country, 2021–2028 (Usd Million) 129
8.2.1 Deep Learning 130
8.2.1.1 Deep Learning To See Growing Adoption In Drug Discovery 130
Table 21 Artificial Intelligence In Drug Discovery Market For Deep Learning, By Country, 2021–2028 (Usd Million) 130
8.2.2 Supervised Learning 131
8.2.2.1 Applications In Drug Repositioning To Drive Market 131
Table 22 Artificial Intelligence In Drug Discovery Market For Supervised Learning, By Country, 2021–2028 (Usd Million) 131
8.2.3 Reinforcement Learning 132
8.2.3.1 Potential For Machines And Software To Automatically Determine Behavior To Support Adoption 132
Table 23 Artificial Intelligence In Drug Discovery Market For Reinforcement Learning, By Country, 2021–2028 (Usd Million) 132
8.2.4 Unsupervised Learning 133
8.2.4.1 Unpredictability To Affect End-User Adoption 133
Table 24 Artificial Intelligence In Drug Discovery Market For Unsupervised Learning, By Country, 2021–2028 (Usd Million) 133
8.2.5 Other Machine Learning Technologies 134
Table 25 Artificial Intelligence In Drug Discovery Market For Other Machine Learning Technologies, By Country, 2021–2028 (Usd Million) 134
8.3 Natural Language Processing 135
8.3.1 Potential Applications In Data Identification To Support Growth 135
Table 26 Artificial Intelligence In Drug Discovery Market For Natural Language Processing, By Country, 2021–2028 (Usd Million) 135
8.4 Context-Aware Processing & Context-Aware Computing 136
8.4.1 Rising Processing Power, Improved Connectivity To Boost Usage 136
Table 27 Artificial Intelligence In Drug Discovery Market For Context-Aware Processing & Context-Aware Computing, By Country, 2021–2028 (Usd Million) 136
8.5 Other Technologies 137
Table 28 Artificial Intelligence In Drug Discovery Market For Other Technologies, By Country, 2021–2028 (Usd Million) 138

9 Artificial Intelligence In Drug Discovery Market, By Therapeutic Area 139
9.1 Introduction 140
Table 29 Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 140
9.2 Oncology 140
9.2.1 High Prevalence Of Cancer And Shortage Of Effective Cancer Drugs To Drive Segment Growth 140
Table 30 Artificial Intelligence In Drug Discovery Market For Oncology, By Country, 2021–2028 (Usd Million) 141
9.3 Infectious Diseases 141
9.3.1 Rising Epidemic Outbreaks To Boost Drug Discovery Activity 141
Table 31 Artificial Intelligence In Drug Discovery Market For Infectious Diseases, By Country, 2021–2028 (Usd Million) 142
9.4 Neurology 143
9.4.1 Need To Boost Discovery And Development To Drive Market 143
Table 32 Artificial Intelligence In Drug Discovery Market For Neurology, By Country, 2021–2028 (Usd Million) 143
9.5 Cardiovascular Diseases 144
9.5.1 Rising Demand For Cvd Drugs To Drive Segment 144
Table 33 Indicative List Of Developments In Cardiovascular Drug Development 144
Table 34 Artificial Intelligence In Drug Discovery Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 145
9.6 Immunology 145
9.6.1 Growing Drug Pipeline For Immunological Disorders To Favor Market Growth 145
Table 35 Artificial Intelligence In Drug Discovery Market For Immunology, By Country, 2021–2028 (Usd Million) 146
9.7 Metabolic Diseases 146
9.7.1 Role Of Ai In Uncovering Small-Molecule Therapies To Drive Adoption 146
Table 36 Artificial Intelligence In Drug Discovery Market For Metabolic Diseases, By Country, 2021–2028 (Usd Million) 147
9.8 Other Therapeutic Areas 148
Table 37 Artificial Intelligence In Drug Discovery Market For Other Therapeutic Areas, By Country, 2021–2028 (Usd Million) 148

10 Ai In Drug Discovery Market, By Process 149
10.1 Introduction 150
Figure 42 Hit-To-Lead Identification/Lead Generation Segment Held Largest Market Share In 2022 150
Table 38 Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 150
10.2 Target Identification & Selection 151
10.2.1 Development Of New Technologies To Support Market Growth 151
Table 39 Artificial Intelligence In Drug Discovery Market For Target Identification & Selection, By Country, 2021–2028 (Usd Million) 152
10.3 Target Validation 152
10.3.1 Rising Emphasis On Target Validation To Avoid Late-Stage Failure 152
Table 40 Artificial Intelligence In Drug Discovery Market For Target Validation, By Country, 2021–2028 (Usd Million) 153
10.4 Hit Identification & Prioritization 154
10.4.1 Need For Large-Scale Data Analysis To Drive Adoption 154
Table 41 Artificial Intelligence In Drug Discovery Market For Hit Identification & Prioritization, By Country, 2021–2028 (Usd Million) 154
10.5 Hit-To-Lead Identification/Lead Generation 155
10.5.1 Hit-To-Lead Identification To Hold Largest Market Share 155
Table 42 Artificial Intelligence In Drug Discovery Market For Hit-To-Lead Identification/Lead Generation, By Country, 2021–2028 (Usd Million) 156
10.6 Lead Optimization 156
10.6.1 Need For Transparent Presentation And Analysis To Boost Focus On Lead Optimization 156
Table 43 Artificial Intelligence In Drug Discovery Market For Lead Optimization, By Country, 2021–2028 (Usd Million) 157
10.7 Candidate Selection & Validation 158
10.7.1 Possibility Of Drug Failure During Development To Drive Adoption Of Candidate Validation Services 158
Table 44 Artificial Intelligence In Drug Discovery Market For Candidate Selection & Validation, By Country, 2021–2028 (Usd Million) 159

11 Ai In Drug Discovery Market, By Use Case 160
11.1 Introduction 161
Figure 43 Small-Molecule Design & Optimization Segment Accounted For Largest Market Share In 2022 161
Table 45 Ai In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 162
11.2 Small-Molecule Design & Optimization 162
11.2.1 Availability Of Well-Validated Ai Tools To Boost Market Growth 162
Table 46 Ai In Drug Discovery Market For Small-Molecule Design & Optimization, By Country, 2021–2028 (Usd Million) 163
11.3 Understanding Disease 164
11.3.1 Rising Data Mining To Link Targets To Diseases And Drug Repurposing To Drive Market 164
Table 47 Ai In Drug Discovery Market For Understanding Disease, By Country, 2021–2028 (Usd Million) 165
11.4 Safety & Toxicity 165
11.4.1 Toxicology And Off-Target Effect Prediction, Pk/Pd Simulation, And Qsp Modeling To Propel Market Growth 165
Table 48 Ai In Drug Discovery Market For Safety & Toxicity, By Country, 2021–2028 (Usd Million) 167
11.5 Vaccine Design & Optimization 167
11.5.1 Growing Adoption Of Ai For Epitope Selection, Prediction, And Binding To Augment Market Growth 167
Table 49 Ai In Drug Discovery Market For Vaccine Design & Optimization, By Country, 2021–2028 (Usd Million) 168
11.6 Antibody & Other Biologic Design & Optimization 169
11.6.1 Growing Adoption Of Ai For Antibody Property Prediction To Drive Market 169
Table 50 Ai In Drug Discovery Market For Antibody & Other Biologic Design & Optimization, By Country, 2021–2028 (Usd Million) 170

12 Artificial Intelligence In Drug Discovery Market, By End User 171
12.1 Introduction 172
Table 51 Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 172
12.2 Pharmaceutical & Biotechnology Companies 172
12.2.1 Rising Demand For Solutions To Cut Time And Costs Of Drug Development To Drive Market 172
Table 52 Indicative List Of Developments Related To Ai In Pharmaceutical & Biotechnology Industry 173
Table 53 Artificial Intelligence In Drug Discovery Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 174
12.3 Contract Research Organizations 175
12.3.1 Growing Trend Of Outsourcing To Provide Significant Opportunities For Contract Research Organizations 175
Table 54 Indicative List Of Collaborations With Cros 175
Table 55 Artificial Intelligence In Drug Discovery Market For Contract Research Organizations, By Country, 2021–2028 (Usd Million) 176
12.4 Research Centers And Academic & Government Institutes 177
12.4.1 Segment To Register Highest Cagr Over Forecast Period 177
Table 56 Indicative List Of Research Collaborations 177
Table 57 Artificial Intelligence In Drug Discovery Market For Research Centers And Academic & Government Institutes, By Country, 2021–2028 (Usd Million) 178

13 Artificial Intelligence In Drug Discovery Market, By Region 179
13.1 Introduction 180
Table 58 Artificial Intelligence In Drug Discovery Market, By Region, 2021–2028 (Usd Million) 180
13.2 North America 180
13.2.1 North America: Recession Impact 180
Figure 44 North America: Artificial Intelligence In Drug Discovery Market Snapshot 181
Table 59 North America: Artificial Intelligence In Drug Discovery Market, By Country, 2021–2028 (Usd Million) 182
Table 60 North America: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 182
Table 61 North America: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 182
Table 62 North America: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 183
Table 63 North America: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 183
Table 64 North America: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 184
Table 65 North America: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 184
Table 66 North America: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 185
13.2.2 Us 185
13.2.2.1 Strong Economy And Trend Of Early Adoption Of Technologies To Drive Market 185
Figure 45 Distribution Of R&D Companies, By Country/Region (2021 Vs. 2022) 186
Table 67 Us: Indicative List Of Strategic Developments 186
Table 68 Us: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 187
Table 69 Us: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 187
Table 70 Us: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 188
Table 71 Us: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area 2021–2028 (Usd Million) 188
Table 72 Us: Artificial Intelligence In Drug Discovery Market, By Process 2021–2028 (Usd Million) 189
Table 73 Us: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 189
Table 74 Us: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 190
13.2.3 Canada 190
13.2.3.1 Growing Research On Ai Technologies And Emergence Of New Ai-Based Start-Ups To Support Market Growth 190
Table 75 Canada: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 191
Table 76 Canada: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 191
Table 77 Canada: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 192
Table 78 Canada: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 192
Table 79 Canada: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 193
Table 80 Canada: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 193
Table 81 Canada: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 194
13.2.4 Mexico 194
13.2.4.1 Government Initiatives To Support Market Growth 194
Table 82 Mexico: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 194
Table 83 Mexico: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 195
Table 84 Mexico: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 195
Table 85 Mexico: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 196
Table 86 Mexico: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 196
Table 87 Mexico: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 197
Table 88 Mexico: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 197
13.3 Europe 197
13.3.1 Europe: Recession Impact 198
Table 89 Europe: Artificial Intelligence In Drug Discovery Market, By Country, 2021–2028 (Usd Million) 199
Table 90 Europe: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 199
Table 91 Europe: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 200
Table 92 Europe: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 200
Table 93 Europe: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 201
Table 94 Europe: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 201
Table 95 Europe: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 202
Table 96 Europe: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 202
13.3.2 Uk 202
13.3.2.1 Uk To Hold Largest Share In Europe 202
Table 97 Uk: Indicative List Of Strategic Developments 203
Table 98 Uk: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 204
Table 99 Uk: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 204
Table 100 Uk: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 205
Table 101 Uk: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 205
Table 102 Uk: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 206
Table 103 Uk: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 206
Table 104 Uk: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 207
13.3.3 Germany 207
13.3.3.1 Government Support And Favorable Training Programs To Propel Market Growth 207
Table 105 Germany: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 208
Table 106 Germany: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 208
Table 107 Germany: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 209
Table 108 Germany: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 209
Table 109 Germany: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 210
Table 110 Germany: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 210
Table 111 Germany: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 211
13.3.4 France 211
13.3.4.1 Strong Government Support And Favorable Strategies & Initiatives To Drive Market 211
Table 112 France: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 211
Table 113 France: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 212
Table 114 France: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 212
Table 115 France: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 213
Table 116 France: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 213
Table 117 France: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 214
Table 118 France: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 214
13.3.5 Italy 214
13.3.5.1 Strong Pharmaceutical Industry To Support Market Growth 214
Table 119 Italy: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 215
Table 120 Italy: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 215
Table 121 Italy: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 216
Table 122 Italy: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 216
Table 123 Italy: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 217
Table 124 Italy: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 217
Table 125 Italy: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 218
13.3.6 Rest Of Europe 218
Table 126 Rest Of Europe: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 218
Table 127 Rest Of Europe: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 219
Table 128 Rest Of Europe: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 219
Table 129 Rest Of Europe: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 220
Table 130 Rest Of Europe: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 220
Table 131 Rest Of Europe: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 221
Table 132 Rest Of Europe: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 221
13.4 Asia Pacific 222
13.4.1 Asia Pacific: Recession Impact 222
Table 133 Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Country, 2021–2028 (Usd Million) 223
Table 134 Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 223
Table 135 Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 223
Table 136 Asia Pacific: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 224
Table 137 Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 224
Table 138 Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 225
Table 139 Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 225
Table 140 Asia Pacific: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 226
13.4.2 Japan 226
13.4.2.1 Japan To Dominate Apac Market 226
Table 141 Japan: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 227
Table 142 Japan: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 227
Table 143 Japan: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 228
Table 144 Japan: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 228
Table 145 Japan: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 229
Table 146 Japan: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 229
Table 147 Japan: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 230
13.4.3 China 230
13.4.3.1 Growing Cmo Market And Cross-Industry Collaborations To Drive Market 230
Table 148 China: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 231
Table 149 China: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 231
Table 150 China: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 232
Table 151 China: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 232
Table 152 China: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 233
Table 153 China: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 233
Table 154 China: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 234
13.4.4 India 234
13.4.4.1 Steady Adoption Of Ai Technologies To Support Market Growth 234
Table 155 India: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 235
Table 156 India: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 235
Table 157 India: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 236
Table 158 India: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 236
Table 159 India: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 237
Table 160 India: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 237
Table 161 India: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 238
13.4.5 Rest Of Asia Pacific 238
Table 162 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 239
Table 163 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 239
Table 164 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 240
Table 165 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 240
Table 166 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 241
Table 167 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 241
Table 168 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 242
13.5 South America 242
13.5.1 Shortage Of Skilled Labor And Growing Requirements To Drive Ai Adoption 242
13.5.2 South America: Recession Impact 243
Table 169 South America: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 243
Table 170 South America: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 243
Table 171 South America: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 244
Table 172 South America: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 244
Table 173 South America: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 245
Table 174 South America: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 245
Table 175 South America: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 246
13.6 Middle East & Africa 246
13.6.1 Limited Company Presence And Large Scope For Growth To Favor Ai Market 246
13.6.2 Middle East & Africa: Recession Impact 246
Table 176 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Offering, 2021–2028 (Usd Million) 247
Table 177 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Technology, 2021–2028 (Usd Million) 247
Table 178 Middle East & Africa: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2021–2028 (Usd Million) 248
Table 179 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021–2028 (Usd Million) 248
Table 180 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Process, 2021–2028 (Usd Million) 249
Table 181 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Use Case, 2021–2028 (Usd Million) 249
Table 182 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By End User, 2021–2028 (Usd Million) 250

14 Competitive Landscape 251
14.1 Key Player Strategies/Right To Win 251
Table 183 Overview Of Strategies Adopted By Key Ai In Drug Discovery Players, February 2021– May 2022 252
14.2 Revenue Analysis 256
Figure 46 Revenue Analysis Of Top Market Players, 2022 256
14.3 Market Share Analysis 257
Figure 47 Ai In Drug Discovery Market: Market Share Analysis, 2022 258
Table 184 Ai In Drug Discovery Market: Degree Of Competition 258
14.4 Company Evaluation Matrix 260
14.4.1 Stars 260
14.4.2 Emerging Leaders 260
14.4.3 Pervasive Players 260
14.4.4 Participants 261
Figure 48 Ai In Drug Discovery Market: Company Evaluation Matrix, 2022 261
14.4.5 Company Footprint 262
Table 185 Use Case Footprint (24 Companies) 262
Table 186 Process Footprint (24 Companies) 263
Table 187 Region Footprint (24 Companies) 264
Table 188 Company Footprint (24 Companies) 265
14.5 Start-Up/Sme Evaluation Matrix 266
14.5.1 Progressive Companies 266
14.5.2 Responsive Companies 266
14.5.3 Dynamic Companies 266
14.5.4 Starting Blocks 266
Figure 49 Ai In Drug Discovery Market: Start-Up/Sme Evaluation Matrix, 2022 267
14.5.5 Ai In Drug Discovery Market: Competitive Benchmarking 268
Table 189 Ai In Drug Discovery Market: Detailed List Of Key Smes/Start-Ups 268
Table 190 Use Case Footprint (Start-Ups/Smes) 269
Table 191 Process Footprint (Start-Ups/Smes) 270
Table 192 Region Footprint (Start-Ups/Smes) 270
Table 193 Company Footprint (Start-Ups/Smes) 271
14.6 Competitive Scenarios And Trends 271
14.6.1 Product Launches & Enhancements 271
Table 194 Ai In Drug Discovery Market: Product Launches & Enhancements, 2021–2023 271
14.6.2 Deals 273
Table 195 Ai In Drug Discovery Market: Deals, 2021–2023 273
14.6.3 Other Developments 274
Table 196 Ai In Drug Discovery Market: Other Developments, 2021–2023 274

15 Company Profiles 276
15.1 Key Players 276
(Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right To Win, Strategic Choices Made, And Weaknesses And Competitive Threats))*
15.1.1 Nvidia Corporation 276
Table 197 Nvidia Corporation: Company Overview 276
Figure 50 Nvidia Corporation: Company Snapshot, 2022 277
Table 198 Nvidia Corporation: Products/Solutions/Services Offered 278
Table 199 Nvidia Corporation: Product/Service Launches 279
Table 200 Nvidia Corporation: Deals 280
15.1.2 Exscientia 284
Table 201 Exscientia: Company Overview 284
Figure 51 Exscientia: Company Snapshot (2022) 285
Table 202 Exscientia: Products/Solutions/Services Offered 285
Table 203 Exscientia: Product/Service Launches 287
Table 204 Exscientia: Deals 287
Table 205 Exscientia: Other Developments 292
15.1.3 Google 294
Table 206 Google: Company Overview 294
Figure 52 Google: Company Snapshot (2022) 295
Table 207 Google: Products/Solutions/Services Offered 296
Table 208 Google: Product/Service Launches 297
Table 209 Google: Deals 297
Table 210 Google: Other Developments 298
15.1.4 Benevolentai 299
Table 211 Benevolentai: Company Overview 299
Figure 53 Benevolentai: Company Snapshot (2022) 299
Table 212 Benevolentai: Products/Solutions/Services Offered 300
Table 213 Benevolentai: Deals 300
15.1.5 Recursion 303
Table 214 Recursion: Company Overview 303
Figure 54 Recursion: Company Snapshot (2022) 303
Table 215 Recursion: Products/Solutions/Services Offered 304
Table 216 Recursion: Product/Service Launches 304
Table 217 Recursion: Deals 305
Table 218 Recursion: Other Developments 306
15.1.6 Insilico Medicine 307
Table 219 Insilico Medicine: Company Overview 307
Table 220 Insilico Medicine: Products/Solutions/Services Offered 308
Table 221 Insilico Medicine: Product/Service Launches 309
Table 222 Insilico Medicine: Deals 310
Table 223 Insilico Medicine: Other Developments 313
15.1.7 Schrödinger, Inc. 314
Table 224 Schrödinger, Inc.: Company Overview 314
Figure 55 Schrödinger, Inc.: Company Snapshot (2022) 315
Table 225 Schrödinger, Inc.: Products/Solutions/Services Offered 315
Table 226 Schrödinger, Inc.: Deals 316
Table 227 Schrödinger, Inc.: Other Developments 318
15.1.8 Microsoft Corporation 319
Table 228 Microsoft Corporation: Company Overview 319
Figure 56 Microsoft Corporation: Company Snapshot (2023) 320
Table 229 Microsoft Corporation: Products/Solutions/Services Offered 321
Table 230 Microsoft Corporation: Service Launches 321
Table 231 Microsoft Corporation: Deals 322
15.1.9 Atomwise Inc. 323
Table 232 Atomwise Inc.: Company Overview 323
Table 233 Atomwise Inc.: Products/Solutions/Services Offered 323
Table 234 Atomwise Inc.: Deals 324
15.1.10 Illumina, Inc. 325
Table 235 Illumina, Inc.: Company Overview 325
Figure 57 Illumina, Inc.: Company Snapshot (2022) 326
Table 236 Illumina, Inc.: Products/Solutions/Services Offered 326
Table 237 Illumina, Inc.: Product/Service Launches 327
Table 238 Illumina, Inc.: Deals 328
15.1.11 Numedii, Inc. 330
Table 239 Numedii, Inc.: Company Overview 330
Table 240 Numedii, Inc.: Products/Solutions/Services Offered 331
15.1.12 Xtalpi Inc. 332
Table 241 Xtalpi Inc.: Company Overview 332
Table 242 Xtalpi Inc.: Products/Solutions/Services Offered 332
Table 243 Xtalpi Inc.: Deals 333
15.1.13 Iktos 335
Table 244 Iktos: Company Overview 335
Table 245 Iktos: Products/Solutions/Services Offered 336
Table 246 Iktos: Deals 337
Table 247 Iktos: Other Developments 340
15.1.14 Tempus Labs 341
Table 248 Tempus Labs: Company Overview 341
Table 249 Tempus Labs: Products/Solutions/Services Offered 341
Table 250 Tempus Labs: Product/Service Launches 342
Table 251 Tempus Labs: Deals 342
Table 252 Tempus Labs: Other Developments 344
15.1.15 Deep Genomics, Inc. 345
Table 253 Deep Genomics, Inc.: Company Overview 345
Table 254 Deep Genomics, Inc.: Products/Services Offered 345
Table 255 Deep Genomics, Inc.: Deals 346
Table 256 Deep Genomics, Inc.: Other Developments 346
15.1.16 Verge Genomics 347
Table 257 Verge Genomics: Company Overview 347
Table 258 Verge Genomics: Products/Services Offered 347
Table 259 Verge Genomics: Deals 348
15.1.17 Benchsci 349
Table 260 Benchsci: Company Overview 349
Table 261 Benchsci: Products/Solutions/Services Offered 349
Table 262 Benchsci: Product/Service Launches 350
Table 263 Benchsci: Other Developments 350
15.1.18 Insitro 351
Table 264 Insitro: Company Overview 351
Table 265 Insitro: Products/Solutions/Services Offered 351
Table 266 Insitro: Other Developments 352
15.1.19 Valo Health 353
Table 267 Valo Health: Company Overview 353
Table 268 Valo Health: Products/Solutions/Services Offered 353
Table 269 Valo Health: Deals 354
Table 270 Valo Health: Other Developments 355
15.1.20 Bpgbio, Inc. 356
Table 271 Bpgbio, Inc.: Company Overview 356
Table 272 Bpgbio, Inc.: Products/Solutions/Services Offered 356
Table 273 Bpgbio, Inc.: Deals 357
15.2 Other Emerging Players 358
15.2.1 Predictive Oncology, Inc. 358
15.2.2 Labcorp 359
15.2.3 Iqvia Inc. 360
15.2.4 Tencent Holdings Limited 361
15.2.5 Celsius Therapeutics 362
15.2.6 Cytoreason 363
15.2.7 Owkin, Inc. 364
15.2.8 Cloud Pharmaceuticals 364
15.2.9 Evaxion Biotech 365
15.2.10 Standigm 365
15.2.11 Bioage Labs 366
15.2.12 Envisagenics 366
15.2.13 Aria Pharmaceuticals, Inc. 367
*Details On Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right To Win, Strategic Choices Made, And Weaknesses And Competitive Threats) Might Not Be Captured In Case Of Unlisted Companies.

16 Appendix 368
16.1 Discussion Guide 368
16.2 Knowledgestore: Marketsandmarkets’ Subscription Portal 375
16.3 Customization Options 377
16.4 Related Reports 378
16.5 Author Details 379

  • Global Healthcare Workforce Management System Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 86
    Workforce management is an institutional process that maximizes performance levels and competency for an organization. The process includes all The activities needed to maintain a productive workforce, such as field service management, human resource management, performance and training management, data collection, recruiting, budgeting, forecasting, scheduling and analytics. Workforce management provides a common set of performance-based tools and software to support corporate mana......
  • Global Life Science Analytics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Life Science Analytics market size was valued at US$ 23410 million in 2023. With growing demand in downstream market, the Life Science Analytics is forecast to a readjusted size of US$ 47330 million by 2030 with a CAGR of 10.6% during review period. The research report highlights the growth potential of the global Life Science Analytics market. Life Science Analytics are expected to show stable growth in the future market. Ho......
  • Global Patient Engagement Solutions Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Patient Engagement Solutions market size was valued at US$ 14090 million in 2023. With growing demand in downstream market, the Patient Engagement Solutions is forecast to a readjusted size of US$ 53040 million by 2030 with a CAGR of 20.9% during review period. The research report highlights the growth potential of the global Patient Engagement Solutions market. Patient Engagement Solutions are expected to show stable growth ......
  • Global Operating Room Management Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Operating Room Management market size was valued at US$ 4314.6 million in 2023. With growing demand in downstream market, the Operating Room Management is forecast to a readjusted size of US$ 6494.7 million by 2030 with a CAGR of 6.0% during review period. The research report highlights the growth potential of the global Operating Room Management market. Operating Room Management are expected to show stable growth in the futu......
  • Global Healthcare Supply Chain Managements Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Healthcare Supply Chain Managements market size was valued at US$ 2151.2 million in 2023. With growing demand in downstream market, the Healthcare Supply Chain Managements is forecast to a readjusted size of US$ 4098.9 million by 2030 with a CAGR of 9.6% during review period. The research report highlights the growth potential of the global Healthcare Supply Chain Managements market. Healthcare Supply Chain Managements are ex......
  • Global Healthcare Workforce Management System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Healthcare Workforce Management System market size was valued at US$ 1543.3 million in 2023. With growing demand in downstream market, the Healthcare Workforce Management System is forecast to a readjusted size of US$ 3331.2 million by 2030 with a CAGR of 11.6% during review period. The research report highlights the growth potential of the global Healthcare Workforce Management System market. Healthcare Workforce Management ......
  • Global Behavioral Health Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Behavioral Health Software market size was valued at US$ 1641 million in 2023. With growing demand in downstream market, the Behavioral Health Software is forecast to a readjusted size of US$ 3274.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Behavioral Health Software market. Behavioral Health Software are expected to show stable growth in the f......
  • Global Long-term Care Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Long-term Care Software market size was valued at US$ 1339.2 million in 2023. With growing demand in downstream market, the Long-term Care Software is forecast to a readjusted size of US$ 3460.2 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Long-term Care Software market. Long-term Care Software are expected to show stable growth in the future mark......
  • Global Healthcare RCM Outsourcing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Healthcare RCM Outsourcing market size was valued at US$ 19580 million in 2023. With growing demand in downstream market, the Healthcare RCM Outsourcing is forecast to a readjusted size of US$ 40390 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Healthcare RCM Outsourcing market. Healthcare RCM Outsourcing are expected to show stable growth in the f......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs